LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Wilne, Sophie"
  2. AU="Changjin Lee"
  3. AU="Hyunsoo Lee"
  4. AU=Sinha Ian
  5. AU="Bird, M F"

Suchergebnis

Treffer 1 - 10 von insgesamt 17

Suchoptionen

  1. Artikel ; Online: Whole-body MRI for cancer surveillance in ataxia-telangiectasia: A qualitative study of the perspectives of people affected by A-T and their families.

    Neves, Renata / Perez, Blanca de Dios / Tindall, Tierney / Fernandez, Natasha Schneider / Panek, Rafal / Wilne, Sophie / Suri, Mohnish / Whitehouse, William / Jagani, Sumit / Dandapani, Madhumita / Dineen, Robert A / Glazebrook, Cris

    Health expectations : an international journal of public participation in health care and health policy

    2023  Band 26, Heft 3, Seite(n) 1358–1367

    Abstract: Background/objectives: Ataxia-telangiectasia (A-T) is a complex inherited disease associated with an increased risk of malignancy. Surveillance guidelines have demonstrated significant health benefits in other cancer predisposition syndromes. However, ... ...

    Abstract Background/objectives: Ataxia-telangiectasia (A-T) is a complex inherited disease associated with an increased risk of malignancy. Surveillance guidelines have demonstrated significant health benefits in other cancer predisposition syndromes. However, evidence-based guidelines for cancer screening are not currently used in the United Kingdom for people affected by A-T. This study aims to understand how people with A-T and their parents feel about cancer surveillance using whole-body magnetic resonance imaging (MRI) to inform the future development of cancer surveillance guidelines.
    Design/methods: We conducted semistructured interviews with people affected by A-T. Data were analysed inductively using thematic analysis.
    Results: Nine parents of children with A-T and four adults with A-T were interviewed. Five main themes emerged from the data, including (1) cancer screening was considered invaluable with the perceived value of early detection highlighted; (2) the cancer fear can increase anxiety; (3) the perceived limitations around current practice, with the responsibility for monitoring falling too strongly on parents and patients; (4) the need for effective preparation for cancer screening, including clear communication and (5) the challenges associated with MRI screening, where specific recommendations were made for improving the child's experience.
    Conclusion: This study suggests that stakeholders are positive about the perceived advantages of a cancer screening programme. Ongoing support and preparation techniques should be adopted to maximise adherence and minimise adverse psychosocial outcomes.
    Patient or public contribution: People with A-T and parents of people with A-T were actively involved in this study by giving their consent to be interviewed. An independent parent representative contributed to the study, supporting the research team in interpreting and commenting on the appropriateness of the language used in this report.
    Mesh-Begriff(e) Child ; Adult ; Humans ; Ataxia Telangiectasia ; Magnetic Resonance Imaging ; Whole Body Imaging ; Parents/psychology ; Neoplasms/diagnostic imaging
    Sprache Englisch
    Erscheinungsdatum 2023-03-16
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2119434-8
    ISSN 1369-7625 ; 1369-6513
    ISSN (online) 1369-7625
    ISSN 1369-6513
    DOI 10.1111/hex.13756
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Guidelines for the Prophylaxis of Pneumocystis jirovecii Pneumonia (PJP) in Children With Solid Tumors.

    Proudfoot, Rebecca / Phillips, Bob / Wilne, Sophie

    Journal of pediatric hematology/oncology

    2017  Band 39, Heft 3, Seite(n) 194–202

    Abstract: Although it is well-established that children undergoing allogeneic stem cell transplants and treatment for leukemia should be offered prophylaxis against Pneumocystis jirovecii pneumonia, the risk for children with solid malignancies is less certain. ... ...

    Abstract Although it is well-established that children undergoing allogeneic stem cell transplants and treatment for leukemia should be offered prophylaxis against Pneumocystis jirovecii pneumonia, the risk for children with solid malignancies is less certain. This guideline has been developed with the aim of standardizing practice and optimizing the benefit versus risk of prophylactic medication in this group of patients. P. jirovecii pneumonia has a high mortality rate even with prompt antimicrobial treatment. Since prophylaxis with co-trimoxazole is safe, effective, and inexpensive, we suggest that all children with malignancies undergoing immunosuppressive therapy are offered prophylaxis unless there are clear contraindications.
    Mesh-Begriff(e) Antibiotic Prophylaxis/methods ; Child ; Humans ; Neoplasms/complications ; Neoplasms/therapy ; Pneumocystis carinii ; Pneumonia, Pneumocystis/etiology ; Pneumonia, Pneumocystis/microbiology ; Pneumonia, Pneumocystis/prevention & control ; Practice Guidelines as Topic ; Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use
    Chemische Substanzen Trimethoprim, Sulfamethoxazole Drug Combination (8064-90-2)
    Sprache Englisch
    Erscheinungsdatum 2017-02-06
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Practice Guideline
    ZDB-ID 1231152-2
    ISSN 1536-3678 ; 1077-4114 ; 0192-8562
    ISSN (online) 1536-3678
    ISSN 1077-4114 ; 0192-8562
    DOI 10.1097/MPH.0000000000000771
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Evaluating the efficacy and safety of single-agent etoposide intra-CSF chemotherapy in children and young people with relapsed/refractory central nervous system tumours.

    Butler, Anna / Meijer, Lisethe / Liu, Jo-Fen / Chohan, Manjit / Jalloh, Ibrahim / Macarthur, Donald / Parr, Margaret / Wilne, Sophie / Wilson, Shaun / Walker, David / Grundy, Richard / Dandapani, Madhumita

    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery

    2023  Band 39, Heft 6, Seite(n) 1537–1544

    Abstract: Purpose: The aim of the project was to evaluate intra-CSF etoposide administration in a palliative setting for children and young people with relapsed/refractory central nervous system (CNS) tumours, with the primary endpoints being overall survival and ...

    Abstract Purpose: The aim of the project was to evaluate intra-CSF etoposide administration in a palliative setting for children and young people with relapsed/refractory central nervous system (CNS) tumours, with the primary endpoints being overall survival and progression-free survival time. A safety endpoint was to assess the side effect profile and complications of intra-CSF etoposide.
    Methods: Thirty-five patients under the age of 30 years (median age: 5.33 years) were enrolled onto the project. The cross-centre study was a service evaluation, with a data collection spreadsheet designed in Nottingham and completed by both Nottingham and Oxford centres. Data was analysed using SPSS, assessing the overall survival and progression-free survival times, as well as the 6-month and 1-year survival rates.
    Results: The median overall survival and progression-free survival times were 10.97 and 5.91 months, respectively. The 6-month and 1-year overall survival rates were 67% and 48%, and the progression-free survival rates were 50% and 22%. Age at the start of intra-CSF therapy was significantly associated with overall survival (P = 0.046), with the 6 + age group having improved overall survival. Treatment type was significantly associated with overall survival (P = 0.012), with etoposide intra-CSF treatment being associated with improved overall survival. Treatment duration was significantly associated with both overall survival (P < 0.001) and progression-free survival (P < 0.001).
    Conclusion: Intra-CSF etoposide treatment has shown to increase both overall and progression-free survival significantly, whilst having few side effects and maintaining a good quality of life for patients, reflecting it as a beneficial therapy in the palliative setting.
    Mesh-Begriff(e) Humans ; Child ; Adolescent ; Child, Preschool ; Adult ; Etoposide ; Quality of Life ; Antineoplastic Combined Chemotherapy Protocols ; Central Nervous System Neoplasms/drug therapy ; Progression-Free Survival
    Chemische Substanzen Etoposide (6PLQ3CP4P3)
    Sprache Englisch
    Erscheinungsdatum 2023-03-23
    Erscheinungsland Germany
    Dokumenttyp Journal Article
    ZDB-ID 605988-0
    ISSN 1433-0350 ; 0302-2803 ; 0256-7040
    ISSN (online) 1433-0350
    ISSN 0302-2803 ; 0256-7040
    DOI 10.1007/s00381-023-05872-w
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: Accelerating diagnosis for childhood brain tumours: an analysis of the HeadSmart UK population data.

    Shanmugavadivel, Dhurgshaarna / Liu, Jo-Fen / Murphy, Laura / Wilne, Sophie / Walker, David

    Archives of disease in childhood

    2019  Band 105, Heft 4, Seite(n) 355–362

    Abstract: Background: HeadSmart, a public and professional awareness campaign, was launched to enhance awareness of brain tumour symptomatology identified in the Royal College of Paediatrics and Child Health, National Institute for Health and Care Excellence- ... ...

    Abstract Background: HeadSmart, a public and professional awareness campaign, was launched to enhance awareness of brain tumour symptomatology identified in the Royal College of Paediatrics and Child Health, National Institute for Health and Care Excellence-accredited guideline. Quality improvement data showed a reduction in diagnostic interval nationally. To reach the government target of 4 weeks, we need to identify subgroups with ongoing delays.
    Methods: Incident cases of brain tumours (0-18) diagnosed between January 2011 and May 2013 across 18 UK centres were included. Anonymised data including demographics, diagnosis and date of symptom onset/presentation were collected. Key outcome measures, total diagnostic interval (TDI), patient interval (PI) and system interval (SI) were calculated. Subanalysis by age, tumour grade and location was also performed.
    Results: Young children (0-5 years) accounted for 38% of cases, with a peak age at diagnosis of 2 years. Central tumours experienced longest intervals with a median TDI of 10.5 weeks, PI of 3.2 weeks and SI of 2.9 weeks. Craniopharyngioma, low-grade glioma and optic pathway gliomas had the longest TDIs with a median of 15.1, 11.9 and 10.4 weeks, respectively. The greatest proportion of delay was in the SI. The 12-18 age group had a median TDI of 12.1 weeks, compared with 8 weeks for the 5-11 age group and 6 weeks for the 0-5 age group (p<0.001).
    Conclusions: Clear patterns of intervals for different age groups and anatomical locations have been demonstrated. Tailoring education and awareness strategies to ensure earlier diagnosis for central tumours and young people is crucial to minimise brain injury, subsequent disability and late effects of treatment for 70% of survivors.
    Mesh-Begriff(e) Adolescent ; Brain Neoplasms/diagnosis ; Brain Neoplasms/epidemiology ; Child ; Child, Preschool ; Early Detection of Cancer ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Quality Improvement ; Retrospective Studies ; United Kingdom/epidemiology
    Sprache Englisch
    Erscheinungsdatum 2019-10-25
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 524-1
    ISSN 1468-2044 ; 0003-9888 ; 1359-2998
    ISSN (online) 1468-2044
    ISSN 0003-9888 ; 1359-2998
    DOI 10.1136/archdischild-2018-315962
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Paediatric differentiated thyroid carcinoma: a UK National Clinical Practice Consensus Guideline.

    Howard, Sasha R / Freeston, Sarah / Harrison, Barney / Izatt, Louise / Natu, Sonali / Newbold, Kate / Pomplun, Sabine / Spoudeas, Helen A / Wilne, Sophie / Kurzawinski, Tom R / Gaze, Mark N

    Endocrine-related cancer

    2022  Band 29, Heft 11, Seite(n) G1–G33

    Abstract: This guideline is written as a reference document for clinicians presented with the challenge of managing paediatric patients with differentiated thyroid carcinoma up to the age of 19 years. Care of paediatric patients with differentiated thyroid ... ...

    Abstract This guideline is written as a reference document for clinicians presented with the challenge of managing paediatric patients with differentiated thyroid carcinoma up to the age of 19 years. Care of paediatric patients with differentiated thyroid carcinoma differs in key aspects from that of adults, and there have been several recent developments in the care pathways for this condition; this guideline has sought to identify and attend to these areas. It addresses the presentation, clinical assessment, diagnosis, management (both surgical and medical), genetic counselling, follow-up and prognosis of affected patients. The guideline development group formed of a multi-disciplinary panel of sub-speciality experts carried out a systematic primary literature review and Delphi Consensus exercise. The guideline was developed in accordance with The Appraisal of Guidelines Research and Evaluation Instrument II criteria, with input from stakeholders including charities and patient groups. Based on scientific evidence and expert opinion, 58 recommendations have been collected to produce a clear, pragmatic set of management guidelines. It is intended as an evidence base for future optimal management and to improve the quality of clinical care of paediatric patients with differentiated thyroid carcinoma.
    Mesh-Begriff(e) Adult ; Child ; Humans ; Prognosis ; Thyroid Neoplasms/diagnosis ; Thyroid Neoplasms/pathology ; Thyroid Neoplasms/therapy ; United Kingdom ; Young Adult
    Sprache Englisch
    Erscheinungsdatum 2022-09-07
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1218450-0
    ISSN 1479-6821 ; 1351-0088
    ISSN (online) 1479-6821
    ISSN 1351-0088
    DOI 10.1530/ERC-22-0035
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: UK survey of Pneumocystis jirovecii pneumonia (PJP) prophylaxis use in paediatric oncology patients.

    Proudfoot, Rebecca / Cox, Rachel / Phillips, Bob / Wilne, Sophie

    Archives of disease in childhood

    2014  Band 100, Heft 1, Seite(n) 115

    Mesh-Begriff(e) Anti-Infective Agents/therapeutic use ; Health Surveys ; Humans ; Pneumocystis carinii ; Pneumonia, Pneumocystis/epidemiology ; Pneumonia, Pneumocystis/microbiology ; Pneumonia, Pneumocystis/prevention & control ; Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use ; United Kingdom
    Chemische Substanzen Anti-Infective Agents ; Trimethoprim, Sulfamethoxazole Drug Combination (8064-90-2)
    Sprache Englisch
    Erscheinungsdatum 2014-10-16
    Erscheinungsland England
    Dokumenttyp Letter
    ZDB-ID 524-1
    ISSN 1468-2044 ; 0003-9888 ; 1359-2998
    ISSN (online) 1468-2044
    ISSN 0003-9888 ; 1359-2998
    DOI 10.1136/archdischild-2014-307515
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Development of cancer surveillance guidelines in ataxia telangiectasia: A Delphi-based consensus survey of international experts.

    Neves, Renata / De Dios Perez, Blanca / Panek, Rafal / Jagani, Sumit / Wilne, Sophie / Bhatt, Jayesh M / Caputi, Caterina / Cirillo, Emilia / Coman, David J / Dückers, Gregor / Gilbert, Donald L / Kay Koenig, Mary / Mansour, Lobna / McDermott, Elizabeth / Pauni, Micaela / Pignata, Claudio / Perlman, Susan L / Porras, Oscar / Betina Porto, Mariela /
    Schon, Katherine / Soler-Palacin, Pere / Nick Russo, Sam / Takagi, Masatoshi / Tischkowitz, Marc / Wainwright, Claire / Dandapani, Madhumita / Glazebrook, Cristine / Suri, Mohnish / Whitehouse, William P / Dineen, Robert A

    Cancer medicine

    2023  Band 12, Heft 13, Seite(n) 14663–14673

    Abstract: Background/objectives: Ataxia telangiectasia (A-T) is a multiorgan disorder with increased vulnerability to cancer. Despite this increased cancer risk, there are no widely accepted guidelines for cancer surveillance in people affected by A-T. We aimed ... ...

    Abstract Background/objectives: Ataxia telangiectasia (A-T) is a multiorgan disorder with increased vulnerability to cancer. Despite this increased cancer risk, there are no widely accepted guidelines for cancer surveillance in people affected by A-T. We aimed to understand the current international practice regarding cancer surveillance in A-T and agreed-upon approaches to develop cancer surveillance in A-T.
    Design/methods: We used a consensus development method, the e-Delphi technique, comprising three rounds. Round 1 consisted of a Delphi questionnaire and a survey that collected the details of respondents' professional background, experience, and current practice of cancer surveillance in A-T. Rounds 2 and 3 were designed based on previous rounds and modified according to the comments made by the panellists. The pre-specified consensus threshold was ≥75% agreement.
    Results: Thirty-five expert panellists from 13 countries completed the study. The survey indicated that the current practice of cancer surveillance varies widely between experts and centres'. Consensus was reached that evidence-based guidelines are needed for cancer surveillance in people with A-T, with separate recommendations for adults and children. Statements relating to the tests that should be included, the age for starting and stopping cancer surveillance and the optimal surveillance interval were also agreed upon, although in some areas, the consensus was that further research is needed.
    Conclusion: The international expert consensus statement confirms the need for evidence-based cancer surveillance guidelines in A-T, highlights key features that the guidelines should include, and identifies areas of uncertainty in the expert community. This elucidates current knowledge gaps and will inform the design of future clinical trials.
    Mesh-Begriff(e) Adult ; Child ; Humans ; Ataxia Telangiectasia/complications ; Ataxia Telangiectasia/diagnosis ; Consensus ; Delphi Technique ; Neoplasms ; Surveys and Questionnaires
    Sprache Englisch
    Erscheinungsdatum 2023-06-02
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2659751-2
    ISSN 2045-7634 ; 2045-7634
    ISSN (online) 2045-7634
    ISSN 2045-7634
    DOI 10.1002/cam4.6075
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel: Treatment of medulloblastoma in young children.

    Walker, David A / Wilne, Sophie

    The Lancet. Oncology

    2005  Band 6, Heft 8, Seite(n) 541–542

    Mesh-Begriff(e) Age Factors ; Cerebellar Neoplasms/drug therapy ; Cerebellar Neoplasms/radiotherapy ; Child Development ; Child, Preschool ; Humans ; Infant ; Infant, Newborn ; Medulloblastoma/drug therapy ; Medulloblastoma/radiotherapy ; Prognosis ; Quality of Life ; Salvage Therapy ; Survival Analysis ; Treatment Outcome
    Sprache Englisch
    Erscheinungsdatum 2005-08
    Erscheinungsland England
    Dokumenttyp Comment ; Letter
    ZDB-ID 2049730-1
    ISSN 1474-5488 ; 1470-2045
    ISSN (online) 1474-5488
    ISSN 1470-2045
    DOI 10.1016/S1470-2045(05)70259-X
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: The utility of routine surveillance screening with magnetic resonance imaging (MRI) to detect tumour recurrence in children with low-grade central nervous system (CNS) tumours: a systematic review.

    Stevens, Simon P / Main, Caroline / Bailey, Simon / Pizer, Barry / English, Martin / Phillips, Robert / Peet, Andrew / Avula, Shivaram / Wilne, Sophie / Wheatley, Keith / Kearns, Pamela R / Wilson, Jayne S

    Journal of neuro-oncology

    2018  Band 139, Heft 3, Seite(n) 507–522

    Abstract: Background: Magnetic resonance imaging (MRI) is routinely used as a surveillance tool to detect early asymptomatic tumour recurrence with a view to improving patient outcomes. This systematic review aimed to assess its utility in children with low-grade ...

    Abstract Background: Magnetic resonance imaging (MRI) is routinely used as a surveillance tool to detect early asymptomatic tumour recurrence with a view to improving patient outcomes. This systematic review aimed to assess its utility in children with low-grade CNS tumours.
    Methods: Using standard systematic review methods, twelve databases were searched up to January 2017.
    Results: Seven retrospective case series studies (n = 370 patients) were included, with average follow-up ranging from 5.6 to 7 years. No randomised controlled trials (RCTs) were identified. Due to study heterogeneity only a descriptive synthesis could be undertaken. Imaging was most frequent in the first year post-surgery (with 2-4 scans) reducing to around half this frequency in year two and annually thereafter for the duration of follow-up. Diagnostic yield ranged from 0.25 to 2%. Recurrence rates ranged from 5 to 41%, with most recurrences asymptomatic (range 65-100%). Collectively, 56% of recurrences had occurred within the first year post-treatment (46% in the first 6-months), 68% by year two and 90% by year five. Following recurrence, 90% of patients underwent treatment changes, mainly repeat surgery (72%). Five-year OS ranged from 96 to 100%, while five-year recurrence-free survival ranged from 67 to 100%. None of the studies reported quality of life measures.
    Conclusion: This systematic review highlights the paucity of evidence currently available to assess the utility of MRI surveillance despite it being routine clinical practice and costly to patients, their families and healthcare systems. This needs to be evaluated within the context of an RCT.
    Mesh-Begriff(e) Adolescent ; Central Nervous System Neoplasms/diagnostic imaging ; Central Nervous System Neoplasms/pathology ; Child ; Child, Preschool ; Early Detection of Cancer/methods ; Humans ; Infant ; Infant, Newborn ; Magnetic Resonance Imaging ; Neoplasm Grading ; Neoplasm Recurrence, Local/diagnostic imaging ; Young Adult
    Sprache Englisch
    Erscheinungsdatum 2018-06-09
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Review ; Systematic Review
    ZDB-ID 604875-4
    ISSN 1573-7373 ; 0167-594X
    ISSN (online) 1573-7373
    ISSN 0167-594X
    DOI 10.1007/s11060-018-2901-x
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: The utility of routine surveillance screening with magnetic resonance imaging to detect tumor recurrence/progression in children with high-grade central nervous system tumors: a systematic review.

    Stevens, Simon P / Main, Caroline / Bailey, Simon / Pizer, Barry / English, Martin / Phillips, Bob / Peet, Andrew / Avula, Shivaram / Wilne, Sophie / Wheatley, Keith / Kearns, Pamela R / Wilson, Jayne S

    Pediatric blood & cancer

    2018  Band 66, Heft 2, Seite(n) e27509

    Abstract: Background: Surveillance magnetic resonance imaging (MRI) is routinely used to detect recurrence in children with high-grade central nervous system (CNS) tumors, although no consensus has been reached regarding its effectiveness and whether earlier ... ...

    Abstract Background: Surveillance magnetic resonance imaging (MRI) is routinely used to detect recurrence in children with high-grade central nervous system (CNS) tumors, although no consensus has been reached regarding its effectiveness and whether earlier detection is associated with improved patient outcomes. This review aimed to evaluate this practice and any associated benefits and harms.
    Methods: Systematic searches for relevant studies were undertaken in a number of databases, including MEDLINE and EMBASE, from 1985 to August 2018. Study selection and data extraction was undertaken independently by two reviewers. Due to heterogeneity between studies, no pooling of data was undertaken. Reporting followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
    Results: No comparative studies were identified. Three retrospective observational studies involving 306 patients were reviewed. All had high risk of bias by virtue of study design. Two studies reported outcomes by symptomatic status-both recurrence rates and overall survival for asymptomatic patients were comparable with those for clinically symptomatic patients. No quality-of-life outcomes were reported.
    Conclusion: There is a paucity of evidence to guide clinical practice as to the effectiveness of MRI surveillance in pediatric patients with high-grade CNS tumors. These studies do not clearly demonstrate benefit or harm for the practice. With more research needed, there is a role for researchers to build into future trials data collection on surveillance imaging to give more information for the assessment of imaging frequency and duration in asymptomatic patients. This is an important question not only to clinicians and patients and their families but also from a health service resource perspective.
    Mesh-Begriff(e) Central Nervous System Neoplasms/diagnostic imaging ; Child ; Disease Progression ; Early Detection of Cancer/methods ; Humans ; Magnetic Resonance Imaging/methods ; Neoplasm Recurrence, Local/diagnostic imaging
    Sprache Englisch
    Erscheinungsdatum 2018-11-08
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't ; Systematic Review
    ZDB-ID 2131448-2
    ISSN 1545-5017 ; 1545-5009
    ISSN (online) 1545-5017
    ISSN 1545-5009
    DOI 10.1002/pbc.27509
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang